PNOC014: Phase I Study of Tovorafenib for Children With Relapsed/Recurrent Low-Grade Gliomas and Other Mitogen Activated Protein Kinase Pathway–Activated TumorsKaren Wright, Sabine Mueller, Lianne Greenspan et al.|JCO oncology advances.|2026Cited by 0